British American Tobacco p.l.c. ADR (BTI)
British American Tobacco: Strong Buy On Valuation And Velo Growth
British American Tobacco is rapidly expanding its non-traditional products, particularly Velo nicotine pouches, driving strong adoption among younger users. BTI offers a compelling 5%+ dividend yield and is aggressively returning capital to shareholders through stock buybacks, enhancing total shareholder returns. With a forward P/E of 11.7x, BTI trades at a significant discount to industry peers, providing a high margin of safety for investors.
British American Tobacco: A Good Diversification Play Away From AI
British American Tobacco remains a compelling buy, offering resilient profitability and a business model with inelastic demand for its core products. BTI's operating margins are impressively high for manufacturing, supported by pricing power and stable consumption despite regulatory headwinds. Debt is manageable with a 5.5x interest coverage ratio and robust cash flow, underpinning dividend stability and financial safety.
3 Tobacco Stocks to Keep an Eye on Amid Market Headwinds
PM, BTI and MO are tackling volume pressures and rising costs by expanding smoke-free portfolios and adapting to changing consumer trends.
Wall Street Analysts Think British American Tobacco (BTI) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
US senators question Big Tobacco on lobbying related to FDA policy shift
Six U.S. senators including Democratic whip Dick Durbin and Elizabeth Warren wrote public letters to tobacco giants Reynolds American and Altria on Thursday to ask questions about donations and lobbying of the Trump administration, saying the companies had enjoyed a "lucrative payday" after spending millions to curry favour with the president.
British American Tobacco p.l.c. (BTI) Q2 2026 Sales/Trading Call Transcript
British American Tobacco p.l.c. (BTI) Q2 2026 Sales/Trading Call Transcript
British American Tobacco Cuts Cigarette Outlook But Expects Lift in New-Category Revenue
The company said global industry volumes in its traditional cigarette market would likely be lower than previously expected this year.
British American Tobacco: The Cigarette Bear Case Is Too Simple
British American Tobacco offers attractive risk-adjusted returns amid regulatory upheaval, with strong revenue predictability and resilient cash flow generation. BTI's reported GAAP revenue since 2018 averages £26 billion, with low volatility, underscoring the tobacco market's ongoing stability despite health awareness and new regulations. Free cash flow margins remain robust, averaging 29% (2018–2024), except for a litigation-impacted 2025, supporting solid valuation and dividend sustainability.
The Vice Market Is Shifting
Earlier this month, I headed from Virginia to Florida on the Amtrak auto train. I highly recommend this option instead of driving down I-95.
British American Tobacco: Time To Quit (Downgrade)
British American Tobacco p.l.c. is downgraded from Buy to Hold due to deteriorating fundamentals and limited further upside. BTI faces persistent revenue and volume declines across all major regions, with combustibles and traditional oral segments under pressure. Modern oral products, particularly the Velo brand, are the only growth area, but not enough to offset overall contraction.
British American Tobacco (BTI) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
British American Tobacco: Why This 6% Yield Remains My Largest Holding
British American Tobacco remains a resilient, recession-resistant business, currently trading at a 20% discount to intrinsic value and yielding 6%. BAT's modern oral segment, led by Velo Plus, is accelerating rapidly, with U.S. sales up 297% and global market leadership in this high-margin NGP category. While heated tobacco and vaping segments face competitive and regulatory challenges, BAT's cash-generating combustibles continue to fund dividends, buybacks, and NGP investments.
